Comparison of Endocrine Therapies in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer: A Network Meta-Analysis

Siqi Liu; Xin Sun; Xiaohui Xu; Fangcai Lin

doi:10.4048/jbc.2020.23.e55

Comparison of Endocrine Therapies in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer: A Network Meta-Analysis

Journal of Breast Cancer ◽

10.4048/jbc.2020.23.e55 ◽

2020 ◽

Vol 23 (5) ◽

pp. 460

Author(s):

Siqi Liu ◽

Xin Sun ◽

Xiaohui Xu ◽

Fangcai Lin

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Meta Analysis ◽

Locally Advanced ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Hormone Receptor Positive ◽

Epidermal Growth

Download Full-text

Abstract P1-13-06: Impact of visceral metastases on treatment patterns for hormone-receptor-positive (HR+)/human epidermal growth factor receptor-2-negative (HER2-) metastatic breast cancer (mBC)

10.1158/1538-7445.sabcs14-p1-13-06 ◽

2015 ◽

Author(s):

James Signorovitch ◽

Jenny Wang ◽

Ruo-Ding Tan ◽

Darren Thomason ◽

Andrew Kageleiry ◽

...

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Treatment Patterns ◽

Hormone Receptor Positive ◽

Visceral Metastases ◽

Epidermal Growth

Download Full-text

Abstract P1-09-01: A phase 1b study of abemaciclib plus pembrolizumab for patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer (MBC)

10.1158/1538-7445.sabcs17-p1-09-01 ◽

2018 ◽

Cited By ~ 4

Author(s):

HS Rugo ◽

P Kabos ◽

MN Dickler ◽

WJ John ◽

I Smith ◽

...

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Hormone Receptor Positive ◽

Phase 1B ◽

Epidermal Growth

Download Full-text

Abstract CT108: A phase 1b study of abemaciclib in combination with pembrolizumab for patients (pts) with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) metastatic breast cancer (mBC) (NCT02779751): Preliminary results

10.1158/1538-7445.am2020-ct108 ◽

2020 ◽

Author(s):

Hope S. Rugo ◽

J. Thad Beck ◽

Guy Jerusalem ◽

Hans Wildiers ◽

Peter Kabos ◽

...

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Hormone Receptor Positive ◽

Phase 1B ◽

Epidermal Growth

Download Full-text

Abemaciclib▼ for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) metastatic breast cancer

Cancer Nursing Practice ◽

10.7748/cnp.2020.e1658 ◽

2020 ◽

Author(s):

Pauline Mcllroy

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Hormone Receptor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Hormone Receptor Positive ◽

Epidermal Growth

Download Full-text

Clinical Challenges in the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Literature Review

Advances in Therapy ◽

10.1007/s12325-020-01552-2 ◽

2020 ◽

Author(s):

Gayathri Nagaraj ◽

Cynthia X. Ma

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Literature Review ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Hormone Receptor Positive ◽

Epidermal Growth

Download Full-text

Progression-free survival with endocrine-based therapies following progression on non-steroidal aromatase inhibitor among postmenopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative metastatic breast cancer: a network meta-analysis

Current Medical Research and Opinion ◽

10.1080/03007995.2018.1479246 ◽

2018 ◽

Vol 34 (9) ◽

pp. 1645-1652 ◽

Cited By ~ 4

Author(s):

Rajeev Ayyagari ◽

Derek Tang ◽

Oscar Patterson-Lomba ◽

Zhou Zhou ◽

Jipan Xie ◽

...

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Metastatic Breast Cancer ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Progression Free Survival ◽

Free Survival ◽

Hormone Receptor Positive ◽

Epidermal Growth

Download Full-text

Abstract OT2-04-07: Phase II study of nivolumab in combination with abemaciclib plus endocrine therapy in patients with hormone receptor-positive, human epidermal growth factor receptor-2 negative metastatic breast cancer (WJOG11418B, NEWFLAME trial)

10.1158/1538-7445.sabcs19-ot2-04-07 ◽

2020 ◽

Author(s):

Jun Masuda ◽

Junji Tsurutani ◽

Norikazu Masuda ◽

Manabu Futamura ◽

Koji Matsumoto ◽

...

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase Ii Study ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Hormone Receptor Positive ◽

Epidermal Growth

Download Full-text

Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor–positive/human epidermal growth factor receptor 2–negative metastatic breast cancer in PALOMA-3

European Journal of Cancer ◽

10.1016/j.ejca.2018.08.011 ◽

2018 ◽

Vol 104 ◽

pp. 21-31 ◽

Cited By ~ 17

Author(s):

Massimo Cristofanilli ◽

Angela DeMichele ◽

Carla Giorgetti ◽

Nicholas C. Turner ◽

Dennis J. Slamon ◽

...

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Hormone Receptor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Hormone Receptor Positive ◽

Epidermal Growth

Download Full-text

Time on treatment of everolimus and chemotherapy among postmenopausal women with hormone-receptor-positive/human-epidermal-growth-factor-receptor-2-negative metastatic breast cancer: a retrospective claims study in the US

Current Medical Research and Opinion ◽

10.1185/03007995.2015.1130691 ◽

2016 ◽

Vol 32 (2) ◽

pp. 385-394 ◽

Cited By ~ 5

Author(s):

Nanxin Li ◽

Yanni Hao ◽

Andrew Kageleiry ◽

Miranda Peeples ◽

Anna Fang ◽

...

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Hormone Receptor Positive ◽

The Us ◽

Epidermal Growth

Download Full-text

Efficacy and safety of low-dose everolimus combined with endocrine drugs for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer

Annals of Translational Medicine ◽

10.21037/atm-21-4273 ◽

2021 ◽

Vol 0 (0) ◽

pp. 0-0

Author(s):

Hui-Qiang Zhang ◽

Jin-Mei Zhou ◽

Shao-Hua Zhang ◽

Li Bian ◽

Jin-Yi Xiao ◽

...

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Low Dose ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Efficacy And Safety ◽

Hormone Receptor Positive ◽

Epidermal Growth

Download Full-text